Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis Maddalena SparacoLuigi CarboneSimona Bonavita Review Article Open access 07 September 2023 Pages: 849 - 866
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials Dania AkbarTaeho Greg RheeRoger S. McIntyre Systematic Review 04 October 2023 Pages: 867 - 881
Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis Hecheng WangHaoran WangYanshuo Han Systematic Review 17 August 2023 Pages: 883 - 913
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies Luca ProsperiniShalom HaggiagClaudio Gasperini Systematic Review 23 September 2023 Pages: 915 - 927
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study Yaroslav WinterKatharina SandnerSergiu Groppa Original Research Article Open access 02 October 2023 Pages: 929 - 936
Comment on: “Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder” Uday PandeNitin R. GaikwadAlok Singh Letter to the Editor 01 September 2023 Pages: 937 - 938
Authors’ Reply to Pande et al. Comment on “Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder” Maxwell Z. PriceRichard L. Price Letter to the editor Open access 01 September 2023 Pages: 939 - 940